Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Read the Label Before Buying AIM Stock

One of the few sectors that have enjoyed upside is the pharmaceutical industry. In particular, AIM stock has jumped on a possible Covid-19 treatment. Nevertheless, you want to look carefully at the label before jumping aboard.

This PR Nightmare for GILD Stock Will Eventually Fade

Once touted as a direct coronavirus play, GILD stock is now receiving heat due to a PR nightmare. But this unfortunate development ultimately won’t affect the bigger picture.

8 of the Strangest Stocks Worth Your Time

“Strange” doesn’t usually have a positive connotation, but some of the strangest stocks to buy offer investors an alternative pathway to profitability.

Co-Diagnostics Stock Is a Long-term Play in Disguise

As a near-term speculation, CODX stock might not be appropriate. But in the bigger picture, the coronavirus has taught harsh lessons to nearly every country, making Co-Diagnostics as relevant as it's ever been.

Oil Wars and Bear Markets Are Too Much for Nio Stock

Even under bull market conditions, Nio stock was a risky opportunity. But in a bear market that is especially tough on automakers, Nio is too treacherous.